EPHA2 and cancer: Previous studies concerning the linkage between EphA2 and malignant tumors indicated that an elevated EphA2 found in malignant tumors was a result of deficient phosphorylation of EphA2 itself, leading to the consequent blockage of EphA2 degradation.